To the Editor:
We were very pleased to read the report by Mamas & Mamas (1), which reported success with dehydroepiandrosterone (DHEA) treatment in women with premature ovarian senescence. Considering some of the questions such treatment has generated in the profession when we previously reported a series of controlled studies on DHEA supplementation (2-5), it is, however, of crucial importance that appropriate terminology be used when DHEA results are reported. Read the rest of this entry »